학술논문

Anaphylaxis to Aprotinin in Fibrin Sealant
Document Type
Journal Article
Source
Internal Medicine. 2005, 44(10):1088
Subject
ELISA inhibition
anaphylaxis
aprotinin
fibrin sealant
topical use
Language
English
ISSN
0918-2918
1349-7235
Abstract
A 50-year-old man with chronic otitis media was admitted to our hospital for investigation of lung cancer. He had received repeated instillations of fibrin sealant (Bolheal) in myringoplasty 7 times over 12 months. During the lower lobectomy, soon after fibrin sealant was applied to seal bronchopleural fistulas, systolic blood pressure decreased to 60 mmHg. Treatment with epinephrine and dopamine was required until his condition improved 2 days later. The specific IgE antibody was detected for the solution for fibrinogen and factor XIII containing bovine aprotinin. Cross-reactivity between purified aprotinin and the solution was noted by competitive ELISA inhibition tests.